State Medicines Control Agency to the Ministry of Health of Republic of Lithuania (hereinafter – SMCA) inspected Sanitas AB pharmaceutical activity‘s compliance to the requirements of good distribution practice. In..
MoreSanitas AB received the information from its shareholder Invalda AB that it has executed definitive documentation to transfer a 20.3 % interest in Sanitas AB to Baltic Pharma Limited, an..
MoreThe Management Board and major shareholders of Sanitas AB (“Sanitas” or the “Company”) initiated a strategic review in April 2008, to consider various strategic options available to the Company to..
MoreCenter for Drug Administration and Research of U.S. Food and Drug Administration (FDA) after the inspection of sterile pharmaceutical finished dosage manufacturing facility in Polish pharmaceutical company Jelfa SA classified..
MoreNet profit of Vilniaus baldai AB during September 2008 was 477 thousand LTL (138 thousand EUR), September of previous year – net profit of 174 thousand LTL (51 thousand EUR). EBITDA..
MoreAt the proposal of the president, the Lithuanian Parliament (Seimas) today approved the appointment of Lina Sajytė as a member of the Securities Commission. Ms Sajytė had been working as..
MoreThe Latvian investment management company IPAS Baltikums Asset Management, which was acquired by AB Invalda in September, is changing its name and will now be called Invalda Asset Management Latvia…
MoreIn the new plant of Sanitas AB 191 workplaces were preserved, out of them 131 women workplaces, 85 workplaces of high qualification specialists. It is anticipated to produce completely new..
MoreTurnover of Vilniaus baldai AB during September 2008 was 14 453 thousand LTL (4186 thousand EUR), September of previous year – 12 630 thousand LTL (3 658 thousand EUR). Turnover, during..
More